He’ll be here soon. We’ve had sex before, but I wasn’t on PrEP back then. How’s he going to respond when I tell him, and what’s going to happen?
HIV-positive people who took injectable cabotegravir +
rilpivirine every four or eight weeks as antiretroviral therapy found it more
convenient and discreet than daily pills, also feeling that it eliminated a
“daily reminder of living with HIV”, Deanna Kerrigan and colleagues report in PLOS One. Similarly, HIV-negative men who took injectable cabotegravir
My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.
After years of urging the province for changes, sexual health advocates are hopeful Alberta will finally fund an expensive drug that can prevent the spread of HIV.
Two new qualitative studies from Toronto shed light on how
stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience
of taking it. In the first, young gay men acknowledged that they did not always
use condoms but did not see themselves as the kind of ‘barebacker’ for whom
they thought PrEP was
Health officials hope the provocative campaign will increase awareness of a drug that reduces the risk of HIV by over 90 percent.
A new oral device that is taken once a week in a capsule could deliver two or three antiretroviral drugs and significantly reduce the risk of missing does or of developing drug resistance, according to research published today in Nature Communications.
The investigators describe their device as a 'mini-pillbox' – no
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which — in their view — remains woefully underused.
Months after the launch of PrEP as a HIV-prevention measure, uptake is still lower than expected
Will St Leger, Adam Shanley and several other sexual health advocates have collaborated to create a site full of everything you need to know about PrEP in Ireland.
I no longer use condoms and I have no regrets. Evidence now suggests that, if you take PrEP daily, as I always do, the risks of HIV infection is roughly the same, or lower, than condoms, and I’ve rediscovered a world of pleasure denied to me for more than 30 years.
All 67 county health departments will offer the daily HIV prevention pill Truvada. Several already do.
The BC Ministry of Health will begin covering PrEP at no cost on Jan 1, 2018. The province’s new access to PrEP is in part thanks to a deal worked out between the BC Centre for Excellence in HIV/AIDS and generic manufacturers of the drug.
Rather than relying on assessment of an individual’s sexual
behaviour or of ‘community viral load’, targeting of pre-exposure prophylaxis
(PrEP) and other prevention interventions could in part be based on the
proportion of a person’s social contacts who have unsuppressed HIV. There is a
correlation between young gay men having HIV and their ‘network
A prospective cohort study of gay men attending three clinics
in southern England – 56 Dean Street and Mortimer Market Centre in London and the Brighton & Hove SHAC (Sexual Health & Contraception) service – have found that 23% of HIV-negative
service users who responded to a follow-up questionnaire had used PrEP
HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside the main relationship, was high, and very high in partners who admitted having condomless anal sex with non-primary partners, the 16th European AIDS Conference (EACS 2017) heard recently.
The conference heard
A study of men who have sex with men (MSM) conducted by the
European Centre for Disease Prevention and Control (ECDC) in collaboration with
the gay contact site Hornet has found that pre-exposure prophylaxis (PrEP) usage has not increased, on
average, among its respondents over the proportion reported last year, when a
Scaling up HIV testing to reduce undiagnosed HIV infection
requires a fundamental re-ordering of HIV testing services to make them more
attractive to people at risk, and doing so can bring about enormous changes in
HIV incidence and treatment uptake, delegates heard on the opening day of the
16th European AIDS Conference (EACS 2017)
A cost-effectiveness model developed by Public Health England finds that just one year’s worth of pre-exposure prophylaxis (PrEP), given to gay men during a period of moderate to high HIV risk, would recoup its own costs and save the NHS money within 23 years if PrEP effectiveness was as high
A pre-exposure prophylaxis (PrEP) programme for men who have sex with men in the UK
would not only be cost-effective, but actually cost-saving (in other words,
both improving health and lowering NHS spending), according to an economic
evaluation published by Valentina Cambiano and colleagues in The Lancet Infectious Diseases today.Modifying a wide range